Andrew Monte
Scientific Director & Medical Director · Denver Health Medical Center
Credentials: · · · · · ·
History
Research
Clinical Pharmacology & Therapeutics · 2021 · 335 citations
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review
Systematic review or meta-analysis · Journal of Medical Toxicology · 2017 · Last of 5 authors · 259 citations
Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study
Annals of Internal Medicine · 2019 · First of 12 authors · 131 citations
22 papers · 12 as a resident
15 papers
12 papers
9 papers · 2 as a resident
8 papers
- SP
8 papers
5 papers
4 papers
Grants
- 2026–2030
National Survey Investigating Hallucinogenic Trends (NSIHT)
National Institute on Drug Abuse · R01
Contact PI · $634K · Denver Health and Hospital Authority
- 2024–2028
Personalizing EmerGency/Acute therapeuticS Utilizing Systems Biology (PEGASUS-2)
National Institute of General Medical Sciences · R35
Contact PI · $1.2M · Denver Health and Hospital Authority
- 2026–2028
The Safety and Clinical Outcomes of Psychedelic Use (SCOPE) Center
National Institute on Drug Abuse · U54
PI · $1.4M · Oregon Health & Science University
- 2017–2023
Personalizing EmerGency/Acute therapeuticS Utilizing Systems Biology (PEGASUS)
National Institute of General Medical Sciences · R35
Contact PI · $2.1M · University of Colorado Denver
Clinical trials
- 2014–2017
Pharmacogenetic Prediction of Metoprolol Effectiveness
Principal investigator · Terminated
University of Colorado, Denver
- 2012–2013
Emergency Department (ED) Drug Interaction in Emergency Department Patients
Principal investigator · Completed
University of Colorado, Denver